Provided by Tiger Trade Technology Pte. Ltd.

Glaukos

121.23
+0.82000.68%
Volume:102.98K
Turnover:12.50M
Market Cap:6.96B
PE:-36.94
High:122.35
Open:120.82
Low:120.71
Close:120.41
52wk High:130.69
52wk Low:73.16
Shares:57.43M
Float Shares:55.40M
Volume Ratio:0.30
T/O Rate:0.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2819
EPS(LYR):-3.2819
ROE:-26.38%
ROA:-13.35%
PB:10.61
PE(LYR):-36.94

Loading ...

BRIEF-Glaukos Q4 Sales USD 143 Million Vs. IBES Estimate USD 131.2 Million

Reuters
·
Jan 14

Glaukos Q4 Sales USD 143 Million VS. Ibes Estimate USD 131.2 Million

THOMSON REUTERS
·
Jan 14

Glaukos Outlook FY Sales USD 600-620 Million

THOMSON REUTERS
·
Jan 14

Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance

THOMSON REUTERS
·
Jan 14

Glaukos price target raised to $138 from $112 at Goldman Sachs

TIPRANKS
·
Jan 09

Glaukos (GKOS) Gets a Buy from Piper Sandler

TIPRANKS
·
Jan 08

Glaukos Price Target Maintained With a $116.00/Share by BTIG

Dow Jones
·
Jan 02

S&P 500 Futures Flat In Premarket Trading; United Therapeutics, Intel Lag

Dow Jones
·
Dec 24, 2025

Glaukos Is Maintained at Buy by UBS

Dow Jones
·
Dec 23, 2025

Truist Securities Adjusts Price Target on Glaukos Corp to $145 From $120, Maintains Buy Rating

MT Newswires Live
·
Dec 18, 2025

Glaukos Is Maintained at Buy by Truist Securities

Dow Jones
·
Dec 18, 2025

Glaukos Corporation to Participate in J.P. Morgan Healthcare Conference

Reuters
·
Dec 16, 2025

Glaukos Director Gilbert H. Kliman Reports Disposal of Common Shares

Reuters
·
Dec 12, 2025

Glaukos Corp : Citigroup Raises Target Price to $125 From $113

THOMSON REUTERS
·
Dec 11, 2025

Glaukos Is Maintained at Buy by Needham

Dow Jones
·
Dec 10, 2025

Needham Adjusts Glaukos Price Target to $125 From $117, Maintains Buy Rating

MT Newswires Live
·
Dec 09, 2025

Glaukos Corp : Needham Raises Target Price to $125 From $117

THOMSON REUTERS
·
Dec 09, 2025

U.S. RESEARCH ROUNDUP-AstraZeneca, Confluent, Pepsico

Reuters
·
Dec 09, 2025

Glaukos CFO Alex R. Thurman Reports Sale of Common Shares

Reuters
·
Nov 27, 2025

Why Glaukos (GKOS) Is Up 13.9% After iDose Tops Forecasts and 2025 Outlook Rises

Simply Wall St.
·
Nov 26, 2025